Filana Therapeutics, Inc. Common Stock

FLNANASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
0.72 USD
↘ 0.05 (6.96%)AT CLOSE (11:59 AM EDT)
0.74
↗ 0.02 (2.95%)
POST MARKET (AS OF 07:32 PM EDT)
Post Market
AS OF 07:32 PM EDT
0.74
↗ 0.02 (2.95%)
🔴Market: CLOSED

Shares of Filana Therapeutics, Inc. Common Stock (FLNA) are trading at $0.72. The technical outlook is "Strong Sell" based on moving average alignment, RSI, and MACD signals. Key drivers include negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, FLNA appears attractively valued relative to sector peers across key multiples.

Technical & fundamental data as of Sep 14, 2026.

Open?$0.77
High?$0.77
Low?$0.71
Prev. Close?$0.77
Volume?386.7K
Avg. Volume?281.7K
VWAP?$0.75
Rel. Volume?1.37x
Bid / Ask
Bid?$0.61 × 100
Ask?$0.87 × 100
Spread?$0.26
Midpoint?$0.74
Valuation & Ratios
Market Cap?37.2M
Shares Out?48.3M
Float?45.6M
Float %?94.4%
P/E Ratio?N/A
P/B Ratio?0.58
EPS?-$0.88
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.
Themes
Biotech - Drug Development›Neuroscience & CNSBiotech - Drug Development›Rare Disease Therapeutics
Employees
20
Market Cap
37.3M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.filanatx.com
Listed
2000-07-14
Address
6801 N CAPITAL OF TEXAS HIGHWAY
AUSTIN, TX 78731
Phone: 512-501-2444
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental Outlook
Loading...
Short InterestVery High
Short % of Float?13.80%High
Short Interest?6.3M
Days to Cover?32.7
Free Float45.6M
Avg Daily Volume192.7K
Settlement Date2026-08-31
Financial Health
Current Ratio?2.08Strong
Quick Ratio?2.08Strong
Cash Ratio?2.06Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.58CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
Peers
100
S&P
97
1.0CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
3
-66.5%WEAK▾
ROA?
S&P
3
-40.7%WEAK▾
Cash Flow & Enterprise
FCF?$-29304000
Enterprise Value?$-45483920
Fundamentals ratios updated end of day
MarketsMoversWatchlist